Dalian BIO-CHEM Co Ltd
SSE:603360
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (28.8), the stock would be worth ¥8.8 (61% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 74.1 | ¥22.66 |
0%
|
| 3-Year Average | 28.8 | ¥8.8 |
-61%
|
| 5-Year Average | 27.8 | ¥8.5 |
-62%
|
| Industry Average | 42.9 | ¥13.11 |
-42%
|
| Country Average | 29.6 | ¥9.06 |
-60%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
¥21B
|
/ |
Oct 2025
¥216m
|
= |
|
|
¥21B
|
/ |
Dec 2025
¥687.8m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CN |
D
|
Dalian BIO-CHEM Co Ltd
SSE:603360
|
16B CNY | 74.1 | |
| SA |
|
Saudi Basic Industries Corporation SJSC
SAU:2010
|
228.3B SAR | -8.8 | |
| ID |
|
Chandra Asri Pacific PT Tbk
OTC:PTPIF
|
45.6B USD | 41.8 | |
| US |
|
Dow Inc
NYSE:DOW
|
29B USD | -11 | |
| ID |
|
Chandra Asri Petrochemical Tbk PT
IDX:TPIA
|
458.5T IDR | 24.8 | |
| UK |
|
LyondellBasell Industries NV
NYSE:LYB
|
24B USD | -32 | |
| TW |
|
Nan Ya Plastics Corp
TWSE:1303
|
710.6B TWD | 157.3 | |
| CN |
|
Hengli Petrochemical Co Ltd
SSE:600346
|
155.5B CNY | 17.4 | |
| KR |
|
LG Chem Ltd
KRX:051910
|
31.1T KRW | -17.1 | |
| CN |
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
139.4B CNY | 189.3 | |
| CN |
G
|
Guangzhou Tinci Materials Technology Co Ltd
SZSE:002709
|
123.1B CNY | 42.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 17.1 |
| Median | 29.6 |
| 70th Percentile | 57.7 |
| Max | 43 569.3 |
Other Multiples
Dalian BIO-CHEM Co Ltd
Glance View
Dalian BIO-CHEM Co Ltd, rooted in the bustling port city of Dalian, China, specializes in the innovative production and distribution of fine chemicals and intermediates. Founded with the intent to bridge advanced chemical solutions with practical applications, the company has carved a niche in the global market for its high-quality, sustainable chemical products that serve various industries, including pharmaceuticals, agriculture, and materials science. At the heart of Dalian BIO-CHEM's operations lies its cutting-edge research and development team, consistently pushing the boundaries to create environmentally friendly solutions. These efforts have not only bolstered its reputation but also expanded its reach across continents, as it meets the ever-evolving demands of a global clientele. To drive its revenue, Dalian BIO-CHEM capitalizes on a strategic business model that blends large-scale production efficiencies with bespoke chemical solutions. By maintaining robust relationships with raw material suppliers, the company ensures a stable production pipeline, allowing it to offer competitive pricing without compromising on quality. Its earnings are primarily generated through contracts with multinational corporations and smaller businesses that rely on steady supplies of specialty chemicals. Further diversification into custom synthesis services has enabled Dalian BIO-CHEM to address unique client needs, enhancing customer loyalty and expanding its market presence. This strategic agility positions the company not merely as a supplier, but as a trusted partner in the innovation ecosystem of chemical manufacturing.